 <h1>Ticar Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ticarcillin</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ticarcillin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ticar.</p><p><i>Applies to ticarcillin: injectable powder for injection</i></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects have included nausea, vomiting, diarrhea, and pseudomembranous colitis.<sup>[Ref]</sup></p><h3>Local</h3><p>Local side effects have included injection site pain and induration.  Vein irritation and phlebitis may occur when undiluted ticarcillin (the active ingredient contained in Ticar) is injected directly.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Hypersensitivity reactions have included skin rashes, pruritus, urticaria, drug fever, and anaphylaxis.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Some studies show a positive correlation between the degree of hypokalemia, the dose of ticarcillin (the active ingredient contained in Ticar)  and the serum BUN/creatinine ratio, suggesting dehydration and higher doses are risk factors for the development of ticarcillin-associated hypokalemia.<sup>[Ref]</sup></p><p>Metabolic abnormalities have included hypernatremia and hypokalemia.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects have included anemia, thrombocytopenia, leukopenia, neutropenia, and eosinophilia.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Hepatic side effects have included elevations of SGOT and SGPT.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects may include convulsion or neuromuscular excitability with high doses.<sup>[Ref]</sup></p><p id="ref_1">1. Croydon EA, Hermoso C "An evaluation of the safety and tolerance to timentin." J Antimicrob Chemother 17 (1986): 233-40</p><p id="ref_2">2. Sanders CV, Marier RL, Aldridge KE, Derks FW, Martin DH "Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women." Am J Med 79 (1985): 96-100</p><p id="ref_3">3. "Product Information. Ticar (ticarcillin)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_4">4. Shenep JL, Hughes WT, Roberson PK, et al "Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer." N Engl J Med 319 (1988): 1053-8</p><p id="ref_5">5. Link AS, Jr "Efficacy and safety of ticarcillin plus clavulanic acid and piperacillin in patients with lower respiratory tract infections." Am J Med 79 (1985): 86-7</p><p id="ref_6">6. Brown LA, Goldberg ND, Shearer WT "Long-term ticarcillin desensitization by the continuous oral administration of penicillin." J Allergy Clin Immunol 69 (1982): 51-4</p><p id="ref_7">7. Ramirez-Ronda CH, Gutierrez J, Bermudez RH "Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trial." J Antimicrob Chemother 9 (1982): 125-9</p><p id="ref_8">8. Nanji AA, Lindsay J "Ticarcillin associated hypokalemia." Clin Biochem 15 (1982): 118-9</p><p id="ref_9">9. Mostow SR, O'Brien RF "Safety and effectiveness of ticarcillin plus clavulanate potassium in treatment of lower respiratory tract infections." Am J Med 79 (1985): 78-80</p><p id="ref_10">10. Finch RA "Hypernatremia during lithium and ticarcillin therapy." South Med J 74 (1981): 376-7</p><p id="ref_11">11. Welter J, Wittman DH, Freitag V "Ticarcillin therapy of risk patients with infections due to pseudomonas aeruginosa." J Int Med Res 9 (1981): 44-51</p><p id="ref_12">12. Stuart JJ "Ticarcillin-induced hemorrhage in a patient with thrombocytosis." South Med J 73 (1980): 1084-5</p><p id="ref_13">13. Fass RJ, Copelan EA, Brandt JT, Moeschberger ML, Ashton JJ "Platelet-mediated bleeding caused by broad-spectrum penicillins." J Infect Dis 155 (1987): 1242-8</p><p id="ref_14">14. Singh N, Yu VL, Mieles LA, Wagener MM "Beta-lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease." Am J Med 94 (1993): 251-6</p><p id="ref_15">15. Gastineau D, Spector R, Philips D "Severe neutropenia associated with ticarcillin therapy." Ann Intern Med 94 (1981): 711-2</p><h2>More about Ticar (ticarcillin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: antipseudomonal penicillins</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bone infection</li>
<li>Febrile Neutropenia</li>
<li>Intraabdominal Infection</li>
<li>Joint Infection</li>
<li data-more-config-id="list-data-resources-conditions">... +7 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>